scholarly journals A USABILITY EVALUATION OF PORTABLE BREATH KETONE SENSOR DEVICES BY AND FOR YOUNG PEOPLE WITH TYPE 1 DIABETES MELLITUS

Author(s):  
Nicola Brew-Sam ◽  
Jane Desborough ◽  
Anne Parkinson ◽  
Krishnan Murugappan ◽  
Eleni Daskalaki ◽  
...  

Background. Portable breath ketone sensors may help people with Type 1 Diabetes Mellitus (T1DM) avoid episodes of diabetic ketoacidosis; however the design features preferred by users have not been studied. We aimed to elucidate design preferences associated with breath ketone sensors among young people with T1DM aged 12-16 years, their parents, and diabetes educators. Research Designs and Methods. Two commercially available breath ketone sensors, designed for ketogenic diet monitoring, were assessed over one week by ten young people with T1DM following a usability evaluation approach. Participants interacted with the devices at least twice daily for five days, taking breath ketone, blood ketone and blood glucose measurements. Semi-structured interviews were conducted post-testing with participants, parents and two diabetes educators to elicit design preferences to inform the co-design of diabetes breath ketone sensor prototypes. Results. Participants acknowledged the non-invasiveness of breath sensors as compared to blood testing. Affordability, reliability and accuracy were identified as prerequisites for breath ketone sensors used for diabetes management. Design features valued by young people included portability, ease of use, sustainability, readability and suitability for use in public. The time required to use breath sensors was similar to that for blood testing. The requirement to maintain a 10-second breath exhalation posed a challenge for users. Conclusions. Breath ketone sensors for diabetes management bear potential to facilitate ketone testing in young people. Our study affirms features for young people that drive usability of breath sensors among this population, and provides a model of usability assessment of medical devices among young users.

2019 ◽  
Vol 24 (2) ◽  
pp. 99-106
Author(s):  
Michelle Condren ◽  
Samie Sabet ◽  
Laura J. Chalmers ◽  
Taylor Saley ◽  
Jenna Hopwood

Type 1 diabetes mellitus has witnessed significant progress in its management over the past several decades. This review highlights technologic advancements in type 1 diabetes management. Continuous glucose monitoring systems are now available at various functionality and cost levels, addressing diverse patient needs, including a recently US Food and Drug Administration (FDA)–approved implantable continuous glucose monitoring system (CGMS). Another dimension to these state-of-the-art technologies is CGMS and insulin pump integration. These integrations have allowed for CGMS-based adjustments to basal insulin delivery rates and suspension of insulin delivery when a low blood glucose event is predicted. This review also includes a brief discussion of upcoming technologies such as patch-based CGMS and insulin-glucagon dual-hormonal delivery.


Sign in / Sign up

Export Citation Format

Share Document